The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective average particle size of less than about 2000 nm....http://www.google.fr/patents/US7320802?utm_source=gb-gplus-shareBrevet US7320802 - Methods of treatment using nanoparticulate fenofibrate compositions
Methods of treatment using nanoparticulate fenofibrate compositions
